ARDX
Ardelyx, Inc.
NASDAQ · USHealthcareBiotechnology
$5.09-2.12%
Price as of Jul 20, 2026
ARDX profitability
Ardelyx, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 91.9%
- EBITDA margin
- -6.0%
- EBIT margin
- -8.7%
- Net margin
- -13.6%
- Free cash flow margin
- -8.8%
Returns
- Return on equity
- -39.1%
- Return on assets
- -11.5%
- Return on invested capital
- -10.5%
- Asset turnover
- 0.85x
Cash efficiency
- Cash from operations
- -$36.3M
- Cash per share
- $0.96
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.